ArticleClinical rheumatology2018

Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.

Sang-Cheol Bae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.